Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson’s Disease and Cross-Cultural Comparison

The Montreal Cognitive Assessment (MoCA) is one of the most common screening instruments for mild cognitive impairment. However, the standard MoCA is approximately two times longer to administer than the Mini-Mental State Examination. A total of 699 Czech and 175 American participants received the standard MoCA Czech and English versions and in the clinical part, a sample of 102 nondemented patients with Parkinson’s disease (PD). We created a validated Czech short version (s-MoCA-CZ) from the original using item response theory. As expected, s-MoCA-CZ scores were highly correlated with the standard version (Pearson r = .94, p < .001). s-MoCA-CZ also had 80% classification accuracy in the differentiation of PD mild cognitive impairment from PD without impairment. The s-MoCA-CZ, a brief screening tool, is shorter to administer than the standard MoCA. It provides high-classification accuracy for PD mild cognitive impairment and is equivalent to that of the standard MoCA-CZ.

[1]  P. Moberg,et al.  Bridging cognitive screening tests in neurologic disorders: A crosswalk between the short Montreal Cognitive Assessment and Mini-Mental State Examination , 2017, Alzheimer's & Dementia.

[2]  H. Štěpánková,et al.  Montreal Cognitive Assessment and Mini‐Mental State Examination reliable change indices in healthy older adults , 2017, International journal of geriatric psychiatry.

[3]  Marios Politis,et al.  Cognitive decline in Parkinson disease , 2017, Nature Reviews Neurology.

[4]  E. Růžička,et al.  The Diagnostic Accuracy of Parkinson's Disease Mild Cognitive Impairment Battery Using the Movement Disorder Society Task Force Criteria , 2017, Movement disorders clinical practice.

[5]  E. Růžička,et al.  A parsimonious scoring and normative calculator for the Parkinson’s disease mild cognitive impairment battery , 2017, The Clinical neuropsychologist.

[6]  T. Nikolai,et al.  Montreal cognitive assessment (MoCA): Normative data for old and very old Czech adults , 2017, Applied neuropsychology. Adult.

[7]  L. Wojtecki,et al.  Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting , 2016, PloS one.

[8]  Y. Ben-Shlomo,et al.  Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease , 2016, Parkinson's disease.

[9]  P. Moberg,et al.  Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  H. Štěpánková,et al.  Toward the processing speed theory of activities of daily living in healthy aging: normative data of the Functional Activities Questionnaire , 2016, Aging Clinical and Experimental Research.

[11]  J. Trojanowski,et al.  Longitudinal study of normal cognition in Parkinson disease , 2015, Neurology.

[12]  M. Weiner,et al.  An Abbreviated Montreal Cognitive Assessment (MoCA) for Dementia Screening , 2015, The Clinical neuropsychologist.

[13]  R. Gur,et al.  Development of an abbreviated form of the Penn Line Orientation Test using large samples and computerized adaptive test simulation. , 2015, Psychological assessment.

[14]  M. Lamar,et al.  Development, Validity, and Normative Data Study for the 12-Word Philadelphia Verbal Learning Test [czP(r)VLT-12] Among Older and Very Old Czech Adults , 2014, The Clinical neuropsychologist.

[15]  J. Filoteo,et al.  Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment. , 2014, Neuropsychology.

[16]  M. Jahanshahi,et al.  Executive dysfunction in Parkinson's disease: a review. , 2013, Journal of neuropsychology.

[17]  David R. Roalf,et al.  Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging , 2013, Alzheimer's & Dementia.

[18]  T. Robbins,et al.  The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  E. Růžička,et al.  Czech version of the Trail Making Test: normative data and clinical utility. , 2012, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[20]  R. Barker,et al.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines , 2012, Movement disorders : official journal of the Movement Disorder Society.

[21]  M. Weiner,et al.  Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample , 2011, Neurology.

[22]  D. Aarsland,et al.  The economic impact of cognitive impairment in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[23]  T. Anderson,et al.  The MoCA , 2010, Neurology.

[24]  A. Siderowf,et al.  Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease , 2009, Neurology.

[25]  G. Pearlson,et al.  Accounting for estimated IQ in neuropsychological test performance with regression-based techniques , 2009, Journal of the International Neuropsychological Society.

[26]  S. Sawilowsky,et al.  Impact of Rank-Based Normalizing Transformations on the Accuracy of Test Scores , 2009 .

[27]  Seung W. Choi,et al.  Firestar: Computerized Adaptive Testing Simulation Program for Polytomous Item Response Theory Models , 2009 .

[28]  Daniel Weintraub,et al.  Montreal Cognitive Assessment Performance in Patients with Parkinson's Disease with “Normal” Global Cognition According to Mini‐Mental State Examination Score , 2009, Journal of the American Geriatrics Society.

[29]  C. Florkowski Sensitivity, specificity, receiver-operating characteristic (ROC) curves and likelihood ratios: communicating the performance of diagnostic tests. , 2008, The Clinical biochemist. Reviews.

[30]  Alberto L Fernández,et al.  A comparison of normative data for the Trail Making Test from several countries: equivalence of norms and considerations for interpretation. , 2008, Scandinavian journal of psychology.

[31]  Bernard Ravina,et al.  The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[32]  J. Jankovic Parkinson’s disease: clinical features and diagnosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[33]  A. Lang,et al.  A comparison of the mini mental state exam to the montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[34]  E. Tolosa,et al.  Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force , 2007, Movement disorders : official journal of the Movement Disorder Society.

[35]  M. Boustani,et al.  Dementia screening in primary care: is it time? , 2007, JAMA.

[36]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[37]  V. Calabrese,et al.  PROJECTED NUMBER OF PEOPLE WITH PARKINSON DISEASE IN THE MOST POPULOUS NATIONS, 2005 THROUGH 2030 , 2007, Neurology.

[38]  T. Robbins,et al.  Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. , 2007, Brain : a journal of neurology.

[39]  C. Tanner,et al.  Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 , 2007, Neurology.

[40]  Tom Fawcett,et al.  An introduction to ROC analysis , 2006, Pattern Recognit. Lett..

[41]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[42]  Günther Deuschl,et al.  Rivastigmine for dementia associated with Parkinson's disease. , 2004, The New England journal of medicine.

[43]  Norbert K Tanzer,et al.  Bias and equivalence , 2000 .

[44]  P. Fayers Item Response Theory for Psychologists , 2004, Quality of Life Research.

[45]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[46]  Marjan Jahanshahi,et al.  What contributes to quality of life in patients with Parkinson's disease? , 2000, Journal of neurology, neurosurgery, and psychiatry.

[47]  D. Aarsland,et al.  Mental symptoms in Parkinson's disease are important contributors to caregiver distress , 1999, International journal of geriatric psychiatry.

[48]  C. Marsden,et al.  Fronto-striatal cognitive deficits at different stages of Parkinson's disease. , 1992, Brain : a journal of neurology.

[49]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[50]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[51]  A. Ardila,et al.  Sociocultural effects in neuropsychological assessment. , 1985, The International journal of neuroscience.

[52]  F. Lord Applications of Item Response Theory To Practical Testing Problems , 1980 .

[53]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[54]  F. Samejima Estimation of latent ability using a response pattern of graded scores , 1968 .

[55]  Louis Guttman,et al.  A basis for analyzing test-retest reliability , 1945, Psychometrika.

[56]  E. Růžička,et al.  Validity of the Montreal Cognitive Assessment in the Detection of Mild Cognitive Impairment in Parkinson’s Disease , 2020 .

[57]  O. Bezdíček,et al.  Testy verbální fl uence , česká normativní studie pro osoby vyššího věku Tests of Verbal Fluency , Czech Normative Study in Older Patients , 2020 .

[58]  D. Schretlen,et al.  Sociocultural and Language Differences on the Trail Making Test , 2016 .

[59]  David Magis,et al.  Computerized adaptive testing , 2015 .

[60]  J. Reban MONTREALSKÝ KOGNITIVNÍ TEST (MoCA): PØÍNOS K DIAGNOSTICE PREDEMENCÍ , 2006 .

[61]  H. Wainer Computerized adaptive testing: A primer, 2nd ed. , 2000 .